Resero Analytics
Dave Watson is the Founder & CEO of Resero Analytics, where Dave focuses on automating reporting with TurboToxicology to clear backlogs. Prior to founding Resero Analytics, Dave spent 19 years at Eli Lilly and Company as a Senior Research Advisor in drug discovery and development for various disease areas. Dave also has experience as a Post-Doc at NIEHS and a PhD student at Duke University in Pharmacology and Toxicology. Dave holds a Bachelor of Science in Chemistry from St. Lawrence University and an MBA from MIT Sloan School of Management.
This person is not in any teams
Resero Analytics
Resero Analytics creates software and data products to help Pharmaceutical companies, CROs, and Regulators to better manage their Data, to apply Analytics that will extract more value from their data, and to Report it more promptly and more accurately. Our primary focus is on Toxicology and its translation to human drug safety.